First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina
© Pando et al; licensee BioMed Central Ltd. 2006
Received: 26 April 2006
Accepted: 07 September 2006
Published: 07 September 2006
We describe the genetic diversity of currently transmitted strains of HIV-1 in men who have sex with men (MSM) in Buenos Aires, Argentina between 2000 and 2004. Nearly full-length sequence analysis of 10 samples showed that 6 were subtype B, 3 were BF recombinant and 1 was a triple recombinant of subtypes B, C and F. The 3 BF recombinants were 3 different unique recombinant forms. Full genome analysis of one strain that was subtype F when sequenced in pol was found to be a triple recombinant. Gag and pol were predominantly subtype F, while gp120 was subtype B; there were regions of subtype C interspersed throughout. The young man infected with this strain reported multiple sexual partners and sero-converted between May and November of 2004. This study reported for the first time the full genome analysis of a triple recombinant between subtypes B, C and F, that combines in one virus the three most common subtypes in South America.
The great genetic diversity of human immunodeficiency virus type 1 (HIV-1) strains have been recognized since early in the epidemic. Phylogenetic analyses of HIV-1 have revealed the presence of at least 9 subtypes (A-D, F-H, J and K) and 16 circulating recombinant forms (CRFs) worldwide .
In Argentina, previous molecular studies have revealed the presence of two epidemics; the first, among men who have sex with men (MSM), where the viral strains are mostly subtype B, and the second among heterosexuals and injecting drug users where BF recombinants predominate [2, 3]. Further sequencing studies have also revealed the presence of a new CRF, the CRF12_BF  and subtype C . These findings highlight the complex nature of the HIV epidemic in this country.
In this study, we performed nearly full-length genetic sequencing of 10 HIV-1 incident cases who seroconverted in a cohort study among MSM participants in Buenos Aires, Argentina, between the years 2002 and 2005 .
Only those subjects who were willing to participate and provided written informed consent were enrolled. Study participants provided clinic-epidemiologic data using a standardized questionnaire. A sample of anti-coagulated blood was collected in sterile fashion for peripheral blood mononuclear cells (PBMCs) separation. PBMC were separated by Ficoll-Hypaque and maintained at -70°C. PBMCs were used for DNA extraction by the QIAmp DNA extraction kit (QIAgen, Valencia, CA, USA). All samples were subjected to nearly full-length. PCR amplification using the Expand Long Template PCR System (Roche Applied Science, Penzberg, Germany) and a hot start method using a melting wax barrier (Dynawax). The first-round amplification was performed in a volume of 50 μl with primers MSF12b (5'-AAATCTCTAGCAGTGGCGCCCGAACAG-3') and OFMR1 (5'-TGAGGGATCTCTAGTTACCAGAGTC-3'). The second-round amplification was completed using 1μl of the first-round product and primers F2NST (5'-GCGGAGGCTAGAAGGAGAGAGATGG-3') and UNINEF 7 (5'-GCACTCAAGGCAAGCTTTATTGAGGCTTA-3'). This nested strategy amplifies about 9000kb of the HIV genome and was slightly modified from that used previously [7, 8]. The amplified products were then sequenced with Big Dye terminators using an ABI 3100 automated sequencer (Applied Biosystems Inc, Foster City CA).
All sequences were assembled using the software Sequencher (Genecoes Inc., Ann Arbor MI) and examined in a multiple alignment with standard subtype references (Clustal X). Phylogenetic analyses were then conducted using Neighbor-joining method with Kimura's two-parameter model of distance calculation; bootstrap analysis was performed with 100 replicas. To study the ancestral relationships of triple recombinant sequence we conducted a Maximum Parsimony Analysis. Trees were constructed with the software PAUP version 4.0 (Sinaur Associates, Inc., Sunderland, MA) using tree-bisection-reconnection branch swapping (hold 10000) and bootstrap analysis (100 replicates).
Boostcan analysis and a visual inspection of the alignment were used to determine the presence of recombination and to locate breakpoints . After the identification of the breakpoints, each segment was extracted and subjected to phylogenetic analysis to confirm the subtype assignment. Recombinant breakpoint locations were designated relative to HXB-2 (Genbank accession number: K03455).
The structure of this new BCF recombinant showed that gag and pol were predominantly subtype F, while env was mostly subtype B; there were regions of subtype C interspersed throughout (Figures 2a and 2b). The subtype assignments of individual regions of this strain were confirmed in individual analysis shown in Figure 2a. Separate analysis confirmed the subtype assignments made by bootscan analysis; the only exception to this was the first segment, which could not be assigned with confidence to any subtype using any analytic techniques. This may be due to the presence of multiple short fragments of some or all of the 3 subtypes. In addition, maximum parsimony analysis suggested that the subtype C segments of this new recombinant had a common origin with subtype C strains from Brazil; however, no specific origin forsubtypes B or F could be detected (data not shown).
The recombinant sample belonged to a 26-year old man who reported having had multiple male sexual partners, including one from Brazil, and who seroconverted between May and November of 2004. This patient reported a syndrome compatible with primary HIV-1 infection  which included symptoms of fever, fatigue, myalgia, arthralgia, headaches, lymphadenopathy, nausea, vomiting, diarrhea, cough, anorexia, and weight loss of 5 kilograms (11 pounds) within 40 days of HIV diagnosis. The viral load was 64,050 copies per cubic milliliter (log 4.807) and the CD4 count was 391 cells per cubic milliliter. At that time the patient was negative for hepatitis B, hepatitis C and syphilis infections.
This study describes the first nearly full-length genome analysis of HIV-1 from MSM seroincident cases in Buenos Aires, Argentina. Subtype B was found to be the most common strain, however, three samples were found to be BF recombinants, and one sample was identified as a triple recombinant between subtypes B, C and F. Two of the BF recombinants shared some breakpoints with the CRF12_BF ; meanwhile, sample AR163052 showed a different pattern of recombination, suggesting that these samples originated via different recombination events.
Sample AR160677 represents the first triple recombinant of subtypes B, C and F identified in the region using nearly full-length genome sequencing. A report of a partial sequence of a BCF recombinant has been previously reported from southern Brazil , however, the subtype structure of that Brazilian recombinant is different from the structure of the triple recombinant being described.
We do not have additional patient information to determine if the HIV infection was due to a single infection with an already-circulating strain or it represented the result of two (or three) separate infections (i.e. superinfections) which ultimately lead to this unique strain as double and triple HIV infection has been previously described .
These recombinants have emerged in geographic areas where diverse HIV-1 genetic forms are co-circulating and where recombinant viruses are continually being generated in persons infected with two or more variants. Continued efforts to monitor the genetic makeup of HIV strains are critical in order to better assess the ongoing nature of the HIV epidemic in this region as illustrated by this case report.
Nucleotide accession number
GenBank accession numbers for the sequences of this study are [GenBank: DQ383746–DQ383755].
Human Immunodeficiency Virus
circulating recombinant forms
men who have sex with men
peripheral blood mononuclear cells
polymerase chain reaction
The authors wish to thank the medical and administrative staff at the Nexo Asociación Civil NGO for their support in the recruitment of the volunteers, as well as Mr. Sebastian A. for his technical assistance.
This study was partially supported by Work Unit Number 62787A S17 H B0002 (study protocols WRAIR # 914 and DoD # 30587) of the US Military HIV Research Program, Walter Reed Army Institute of Research.
The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense, or other organizations listed.
- HIV Sequence Database Web Site: Theoretical biology and biophysics. Los Alamos National Laboratory. Last accessed March 2006, [http://hiv-web.lanl.gov]
- Avila MM, Pando MA, Carrion G, Peralta LM, Salomon H, Carrillo MG, Sanchez J, Maulen S, Hierholzer J, Marinello M, Negrete M, Russell KL, Carr JK: Two HIV-1 epidemics in Argentina: different genetic subtypes associated with different risk groups. J Acquir Immune Defic Syndr. 29 (4): 422-6. 2002 Apr 1
- Espinosa A, Vignoles M, Carrillo MG, Sheppard H, Donovan R, Peralta LM, Rossi D, Radulich G, Salomon H, Weissenbacher M: Intersubtype BF Recombinants of HIV-1 in a Population of Injecting Drug Users in Argentina. J Acquir Immune Defic Syndr. 36 (1): 630-636. 2004 Apr 20
- Carr JK, Avila M, Gomez Carrillo M, Salomon H, Hierholzer J, Watanaveeradej V, Pando MA, Negrete M, Russell KL, Sanchez J, Birx DL, Andrade R, Vinoles J, McCutchan FE: Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS. 15 (15): F41-7. 10.1097/00002030-200110190-00002. 2001 Oct 19
- Carrion G, Eyzaguirre L, Montano SM, Laguna-Torres V, Serra M, Aguayo N, Avila MM, Ruchansky D, Pando MA, Vinoles J, Perez J, Barboza A, Chauca G, Romero A, Galeano A, Blair PJ, Weissenbacher M, Birx DL, Sanchez JL, Olson JG, Carr JK: Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay. AIDS Res Hum Retroviruses. 2004, 20 (9): 1022-5. 10.1089/aid.2004.20.1022.View ArticlePubMedGoogle Scholar
- Segura M, Sosa Estani S, Marone R, Pando MA, Rey J, Duranti R, Sanchez JL, Weissenbacher M, Avila MM: Buenos Aires Cohort of Men who have sex with Men: Recruitment, retention and seroincidence of HIV and other sexually-transmitted infections. The 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil. 2005Google Scholar
- Salminen MO, Carr JK, Burke DS, McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV-1 by bootscanning. AIDS Res Hum Retroviruses. 1995, 11 (11): 1423-5.View ArticlePubMedGoogle Scholar
- Carr JK, Salminen MO, Koch C, Gotte D, Artenstein AW, Hegerich PA, St Louis D, Burke DS, McCutchan FE: Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol. 1996, 70 (9): 5935-43.PubMed CentralPubMedGoogle Scholar
- Kassutto S, Rosenberg ES: Primary HIV type 1 infection. Clin Infect Dis. 38 (10): 1447-53. 10.1086/420745. 2004 May 15
- Soares MA, De Oliveira T, Brindeiro RM, Diaz RS, Sabino EC, Brigido L, Pires IL, Morgado MG, Dantas MC, Barreira D, Teixeira PR, Cassol S, Tanuri A: Brazilian Network for Drug Resistance Surveillance. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS. 17 (1): 11-21. 10.1097/00002030-200301030-00004. 2003 Jan 3
- Montano SM, Sanchez JL, Laguna-Torres A, Cuchi P, Avila MM, Weissenbacher M, Serra M, Viñoles J, Russi JC, Aguayo N, Galeano AH, Gianella A, Andrade R, Arredondo A, Ramirez E, Acosta ME, Alava A, Montoya O, Guevara A, Manrique H, Sanchez JL, Lama JR, de la Hoz F, Sanchez GI, Ayala C, Pacheco ME, Carrion G, Chauca G, Perez JJ, Negrete M, Russell KL, Bautista CT, Olson JG, Watts DM, Birx DL, Carr JK: Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr. 2005, 40 (1): 57-64. 10.1097/01.qai.0000159667.72584.8b.View ArticlePubMedGoogle Scholar
- van der Kuyl AC, Kozaczynska K, van den Burg R, Zorgdrager F, Back N, Jurriaans S, Berkhout B, Reiss P, Cornelissen M: Triple HIV-1 infection. N Engl J Med. 352 (24): 2557-9. 10.1056/NEJM200506163522420. 2005 Jun 16
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.